GSA CAPITAL PARTNERS LLP - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$1,642,000
+639.6%
14,515
+555.3%
0.11%
+791.7%
Q1 2017$222,000
-91.3%
2,215
-90.7%
0.01%
-92.2%
Q4 2016$2,563,000
-28.8%
23,837
-17.6%
0.15%
-20.7%
Q3 2016$3,600,000
-19.0%
28,921
-30.8%
0.19%
-21.5%
Q2 2016$4,446,000
-4.1%
41,815
+3.3%
0.25%
-16.9%
Q1 2016$4,636,000
-24.8%
40,495
-6.5%
0.30%
-2.0%
Q4 2015$6,168,000
+34.9%
43,294
-15.0%
0.30%
+34.2%
Q3 2015$4,573,000
+2.1%
50,915
+30.8%
0.22%
+30.8%
Q2 2015$4,481,000
+27.8%
38,915
+6.0%
0.17%
+23.7%
Q1 2015$3,507,000
+131.6%
36,715
+63.1%
0.14%
+31.1%
Q4 2014$1,514,000
+26.9%
22,515
+1.8%
0.11%
+68.3%
Q3 2014$1,193,000
+86.1%
22,115
+53.4%
0.06%
+117.2%
Q2 2014$641,000
+214.2%
14,415
+144.6%
0.03%
+93.3%
Q1 2014$204,000
-59.1%
5,893
-65.9%
0.02%
-61.5%
Q4 2013$499,000
-38.8%
17,293
-38.0%
0.04%
-39.1%
Q3 2013$815,000
+40.0%
27,893
+11.2%
0.06%
-7.2%
Q2 2013$582,00025,0930.07%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Segantii Capital Management Ltd 50,000$5,288,0005.80%
RUDMAN ERROL M 37,001$3,934,0003.76%
INDUS CAPITAL PARTNERS, LLC 349,210$37,128,0003.60%
WARBURG PINCUS LLC 1,312,200$139,513,0003.04%
SPQ Asia Capital Ltd 96,000$10,206,0002.63%
OBERWEIS ASSET MANAGEMENT INC/ 82,775$8,801,0002.62%
Ativo Capital Management LLC 94,074$10,002,0002.44%
Sensato Investors LLC 99,764$10,607,0001.72%
Cormorant Asset Management, LP 112,867$12,000,0001.70%
BARING ASSET MANAGEMENT Ltd 131,284$13,958,0001.14%
View complete list of CHINA BIOLOGIC PRODS INC shareholders